Virios Therapeutics Announces Closing of $1.7 Million Public Offering of Common Stock to Commence Preparations for Planned Imc-2 Long-Covid Phase 2B Study
Virios Therapeutics宣佈完成170萬美元的普通股公開發行,開始爲計劃中的Imc-2長冠狀病毒2B期研究做準備
Virios Therapeutics Announces Closing of $1.7 Million Public Offering of Common Stock to Commence Preparations for Planned Imc-2 Long-Covid Phase 2B Study
Virios Therapeutics宣佈完成170萬美元的普通股公開發行,開始爲計劃中的Imc-2長冠狀病毒2B期研究做準備
譯文內容由第三人軟體翻譯。